Lupus-prone MRL/fas^lpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: Concurrent upregulation of somatic hypermutation and class switch DNA recombination

References

• Shlomchik MJ, Madaio MP. The role of antibodies and B cells in the pathogenesis of lupus nephritis. Springer Semin Immunopathol 2003; 24: 363–375
   Google Scholar
• Diamond B. Autoimmunity. Immunol Rev 2005; 204: 5–8
   PubMed Web of Science ®Google Scholar
• Shlomchik MJ, Aucoin AH, Pisetsky DS, Weigert MG. Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci USA 1987; 84: 9150–9154
   PubMed Web of Science ®Google Scholar
• Shlomchik M, Mascelli M, Shan H, Radic MZ, Pisetsky D, Marshak-Rothstein A, Weigert M. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990; 171: 265–292
   PubMed Web of Science ®Google Scholar
• van Es JH, Gmelig Meyling FH, van de Akker WR, Aanstoot H, Derksen RH, Logtenberg T. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J Exp Med 1991; 173: 461–470
   PubMed Web of Science ®Google Scholar
• Winkler TH, Fehr H, Kalden JR. Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur J Immunol 1992; 22: 1719–1728
   PubMed Web of Science ®Google Scholar
• Radic MZ, Mackle J, Erikson J, Mol C, Anderson WF, Weigert M. Residues that mediate DNA binding of autoimmune antibodies. J Immunol 1993; 150: 4966–4977
   PubMed Web of Science ®Google Scholar
• William J, Euler C, Christensen S, Shlomchik MJ. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 2002; 297: 2066–2070
   PubMed Web of Science ®Google Scholar
• Wellmann U, Letz M, Herrmann M, Angermuller S, Kalden JR, Winkler TH. The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci USA 2005; 102: 9258–9263
   PubMed Web of Science ®Google Scholar
• Atassi MZ, Casali P. Molecular mechanisms of autoimmunity. Autoimmunity 2008; 41: 123–132
   PubMed Web of Science ®Google Scholar
• Elkon K, Casali P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol 2008; 4: 491–498
   PubMedGoogle Scholar
• Casali P. Polyclonal B cell activation and antigen-driven antibody response as mechanisms of autoantibody production in SLE. Autoimmunity 1990; 5: 147–150
   PubMed Web of Science ®Google Scholar
• Chai SK, Mantovani L, Kasaian MT, Casali P. Natural autoantibodies. Adv Exp Med Biol 1994; 347: 147–159
   PubMedGoogle Scholar
• Kasaian MT, Ikematsu H, Balow JE, Casali P. Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus. J Immunol 1994; 152: 3137–3151
   PubMed Web of Science ®Google Scholar
• Casali P, Schettino EW. Structure and function of natural antibodies. Curr Top Microbiol Immunol 1996; 120: 167–179
   Google Scholar
• Putterman C, Diamond B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med 1998; 188: 29–38
   PubMed Web of Science ®Google Scholar
• Li Z, Schettino EW, Padlan EA, Ikematsu H, Casali P. Structure-function analysis of a lupus anti-DNA autoantibody: Central role of the heavy chain complementarity-determining region 3 Arg in binding of double- and single-stranded DNA. Eur J Immunol 2000; 30: 2015–2026
   PubMed Web of Science ®Google Scholar
• Wardemann YS, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003; 301: 1374–1377
   PubMed Web of Science ®Google Scholar
• Ichiyoshi Y, Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med 1994; 180: 885–895
   PubMed Web of Science ®Google Scholar
• Ichiyoshi Y, Casali P. Analysis of the structural correlates for self-antigen binding by natural and disease-related autoantibodies. In vitro expression of recombinant and/or mutagenized human IgG. Ann NY Acad Sci 1995; 764: 328–341
   PubMed Web of Science ®Google Scholar
• Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978; 148: 1198–1215
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37: 269–390
   PubMed Web of Science ®Google Scholar
• Murphy ED, Roths JB. A new congenic inbred strain. MRL/Mp Mouse News Lett 1978; 58: 51–52
   Google Scholar
• Liu S, Cerutti A, Casali P, Crow MK. Ongoing immunoglobulin class switch DNA recombination in lupus B cells: Analysis of switch regulatory regions. Autoimmunity 2004; 37: 431–443
   PubMed Web of Science ®Google Scholar
• Kasaian MT, Ikematsu H, Casali P. Identification and analysis of a novel human surface CD5-B lymphocyte subset producing natural antibodies. J Immunol 1992; 148: 2690–2702
   PubMed Web of Science ®Google Scholar
• Hirose S, Wakiya M, Kawano-Nishi Y, Yi J, Sanokawa R, Taki S, Shimamura T, Kishimoto T, Tsurui H, Nishimura H, et al. Somatic diversification and affinity maturation of IgM and IgG anti-DNA antibodies in murine lupus. Eur J Immunol 1993; 23: 2813–2820
   PubMed Web of Science ®Google Scholar
• Kasaian MT, Casali P. Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition. Autoimmunity 1993; 15: 315–329
   PubMed Web of Science ®Google Scholar
• Kasaian MT, Casali P. B-1 cellular origin and VH segment structure of IgG, IgA, and IgM anti-DNA autoantibodies in patients with systemic lupus erythematosus. Ann NY Acad Sci 1995; 764: 410–423
   PubMed Web of Science ®Google Scholar
• Portanova JP, Creadon G, Zhang X, Smith DS, Kotzin BL, Wysocki LJ. An early post-mutational selection event directs expansion of autoreactive B cells in murine lupus. Mol Immunol 1995; 32: 117–135
   Google Scholar
• Dorner T, Heimbacher C, Farner NL, Lipsky PE. Enhanced mutational activity of Vkappa gene rearrangements in systemic lupus erythematosus. Clin Immunol 1999; 92: 188–196
   PubMed Web of Science ®Google Scholar
• Dorner T, Kaschner S, Hansen A, Pruss A, Lipsky PE. Perturbations in the impact of mutational activity on Vlambda genes in systemic lupus erythematosus. Arthritis Res 2001; 3: 368–374
   PubMedGoogle Scholar
• Sekine H, Watanabe H, Gilkeson GS. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. J Immunol 2004; 172: 3913–3921
   PubMed Web of Science ®Google Scholar
• Dorner T, Lipsky PE. Molecular basis of immunoglobulin variable region gene usage in systemic autoimmunity. Clin Exp Med 2005; 4: 159–169
   PubMed Web of Science ®Google Scholar
• Hsu HC, Zhou T, Kim H, Barnes S, Yang P, Wu Q, Zhou J, Freeman BA, Luo M, Mountz JD. Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis. Arthritis Rheum 2006; 54: 343–355
   PubMed Web of Science ®Google Scholar
• Hsu HC, Wu Y, Yang P, Wu Q, Job G, Chen J, Wang J, Accavitti-Loper MA, Grizzle WE, Carter RH, Mountz JD. Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J Immunol 2007; 178: 5357–5365
   PubMed Web of Science ®Google Scholar
• Jiang C, Foley J, Clayton N, Kissling G, Jokinen M, Herbert R, Diaz M. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J Immunol 2007; 178: 7422–7431
   PubMed Web of Science ®Google Scholar
• Chang B, Casali P. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 1994; 15: 367–373
   PubMedGoogle Scholar
• Zan H, Li Z, Yamaji K, Dramitinos P, Cerutti A, Casali P. B cell receptor engagement and T cell contact induce Bcl-6 somatic hypermutation in human B cells: Identity with Ig hypermutation. J Immunol 2000; 165: 830–839
   PubMed Web of Science ®Google Scholar
• Zan H, Komori A, Li Z, Cerutti A, Schaffer A, Flajnik MF, Diaz M, Casali P. The translesion DNA polymerase ζ plays a major role in Ig and bcl-6 somatic hypermutation. Immunity 2001; 14: 643–653
   PubMed Web of Science ®Google Scholar
• Zan H, Shima N, Xu Z, Al-Qahtani A, Evinger AJI, Zhong Y, Schimenti JC, Casali P. The translesion DNA polymerase θ plays a dominant role in immunoglobulin gene somatic hypermutation. EMBO J 2005; 24: 3757–3769
   PubMed Web of Science ®Google Scholar
• Stavnezer J, Amemiya CT. Evolution of isotype switching. Semin Immunol 2004; 16: 257–275
   PubMed Web of Science ®Google Scholar
• Diaz M, Casali P. Somatic immunoglobulin hypermutation. Curr Opin Immunol 2002; 14: 235–240
   PubMed Web of Science ®Google Scholar
• Wu X, Feng J, Komori A, Kim EC, Zan H, Casali P. Immunoglobulin somatic hypermutation: Double-strand DNA breaks, AID and error-prone DNA repair. J Clin Immunol 2003; 23: 235–246
   PubMed Web of Science ®Google Scholar
• Xu Z, Fulop Z, Zhong Y, Evinger AJ, Zan H, Casali P. DNA lesions and repair in immunoglobulin class switch recombination and somatic hypermutation. Ann NY Acad Sci 2005; 1050: 146–162
   PubMed Web of Science ®Google Scholar
• Casali P, Pal Z, Xu Z, Zan H. DNA repair in antibody somatic hypermutation. Trends Immunol 2006; 27: 313–321
   PubMed Web of Science ®Google Scholar
• Di Noia JM, Neuberger MS. Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem 2007; 76: 1–22
   PubMed Web of Science ®Google Scholar
• Neuberger MS, Rada C. Somatic hypermutation: Activation-induced deaminase for C/G followed by polymerase η for A/T. J Exp Med 2007; 204: 7–10
   Google Scholar
• Chaudhuri J, Tian M, Khuong C, Chua K, Pinaud E, Alt FW. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 2003; 422: 726–730
   PubMed Web of Science ®Google Scholar
• Dickerson SK, Market E, Besmer E, Papavasiliou FN. AID mediates hypermutation by deaminating single stranded DNA. J Exp Med 2003; 197: 1291–1296
   PubMed Web of Science ®Google Scholar
• Pham P, Bransteitter R, Petruska J, Goodman MF. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 2003; 424: 103–107
   PubMed Web of Science ®Google Scholar
• Sohail A, Klapacz J, Samaranayake M, Ullah A, Bhagwat AS. Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res 2003; 31: 2990–2994
   PubMed Web of Science ®Google Scholar
• Beale RCL, Oetersen-Mahrt SK, Watt IN, Harris RS, Rada C, Neuberger MS. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: Correlation with mutation spectra in vivo. J Mol Biol 2004; 337: 585–596
   PubMed Web of Science ®Google Scholar
• Papavasiliou FN, Schatz DG. Somatic hypermutation of immunoglobulin genes; merging mechanisms for genetic diversity. Cell 2002; 109: s35–s44
   PubMed Web of Science ®Google Scholar
• Zan H, Wu X, Komori A, Holloman WK, Casali P. AID-dependent generation of resected double-strand DNA breaks and recruitment of Rad52/Rad51 in somatic hypermutation. Immunity 2003; 18: 727–738
   PubMed Web of Science ®Google Scholar
• Rada C, Di Noia JM. Neuberger MS. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol Cell 2004; 16: 163–171
   PubMed Web of Science ®Google Scholar
• Rush JS, Fugmann SD, DG S. Staggered AID-dependent DNA double strand breaks are the predominant DNA lesions targeted to Sμ in Ig class switch recombination. Int Immunol 2004; 16: 549–557
   PubMedGoogle Scholar
• Yabuki M, Fujii MM, Maizels N. The MRE11-RAD50-NBS1 complex accelerates somatic hypermutation and gene conversion of immunoglobulin variable regions. Nat Immunol 2005; 6: 730–736
   PubMed Web of Science ®Google Scholar
• Larson ED, Cummings WJ, Bednarski DW, Maizels N. MRE11/RAD50 cleaves DNA in the AID/UNG-dependent pathway of immunoglobulin gene diversification. Mol Cell 2005; 20: 367–375
   PubMed Web of Science ®Google Scholar
• Casali P, Zan H. Class switching and Myc translocation: How does DNA break?. Nat Immunol 2004; 5: 1101–1103
   PubMed Web of Science ®Google Scholar
• Chaudhuri J, Alt FW. Class-switch recombination: Interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol 2004; 4: 541–552
   PubMed Web of Science ®Google Scholar
• Neuberger MS, Di Noia JM, Beale RC, Williams GT, Yang Z, Rada C. Somatic hypermutation at A.T pairs: Polymerase error versus dUTP incorporation. Nat Rev Immunol 2005; 5: 171–178
   Google Scholar
• Bardwell PD, Woo CJ, Wei K, Li Z, Martin A, Sack SZ, Parris T, Edelmann W, Scharff MD. Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice. Nat Immunol 2004; 5: 224–229
   PubMed Web of Science ®Google Scholar
• Vallur AC, Maizels N. Activities of human exonuclease 1 that promote cleavage of transcribed immunoglobulin switch regions. Proc Natl Acad Sci USA 2008; 105: 16508–16512
   Google Scholar
• Neuberger MS, Harris RS, Di Noia J, Petersen-Mahrt SK. Immunity through DNA deamination. Trends Biochem Sci 2003; 28: 305–312
   PubMedGoogle Scholar
• Yan CT, Boboila C, Souza EK, Franco S, Hickernell TR, Murphy M, Gumaste S, Geyer M, Zarrin AA, Manis JP, Rajewsky K, Alt FW. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 2007; 449: 478–482
   PubMed Web of Science ®Google Scholar
• Chaudhuri J, Basu U, Zarrin A, Yan C, Franco S, Perlot T, Vuong B, Wang J, Phan RT, Datta A, Manis J, Alt FW. Evolution of the immunoglobulin heavy chain class switch recombination mechanism. Adv Immunol 2007; 94: 157–214
   PubMedGoogle Scholar
• Zan H, Cerutti A, Dramitinos P, Schaffer A, Li Z, Casali P. Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ cell line in vitro: Definition of the requirements and the modalities of hypermutation. J Immunol 1999; 162: 3437–3447
   Google Scholar
• Zan H, Cerutti A, Schaffer A, Dramitinos P, Casali P. CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-β. Evidence for TGF-β but not IL-10-dependent direct Sμ → Sα and sequential Sμ → Sγ, Sγ → Sα DNA recombination. J Immunol 1998; 161: 5217–5225
   PubMed Web of Science ®Google Scholar
• Zan H, Casali P. AID- and Ung-dependent generation of staggered double-strand DNA breaks in immunoglobulin class switch DNA recombination: A post-cleavage role for AID. Mol Immunol 2008; 46: 45–61
   PubMed Web of Science ®Google Scholar
• Wu X, Tsai CY, Patam MB, Zan H, Chen JP, Lipkin SM, Casali P. A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation. J Immunol 2006; 176: 5426–5437
   Google Scholar
• Dickerson SK, Market E, Besmer E, Papavasiliou FN. AID mediates hypermutation by deaminating single stranded DNA. J Exp Med 2003; 197: 1291–1296
   PubMed Web of Science ®Google Scholar
• Prochnow C, Bransteitter R, Klein MG, Goodman MF, Chen XS. The APOBEC-2 crystal structure and functional implications for the deaminase AID. Nature 2007; 445: 447–451
   PubMed Web of Science ®Google Scholar
• Bossu P, Singer GG, Andres P, Ettinger R, Marshak-Rothstein A, Abbas AK. Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J Immunol 1993; 151: 7233–7239
   Google Scholar
• Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol 1984; 133: 227–233
   PubMed Web of Science ®Google Scholar
• Bullard DC, King PD, Hicks MJ, Dupont B, Beaudet AL, Elkon KB. Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas mice from early lethality. J Immunol 1997; 159: 2058–2067
   PubMedGoogle Scholar
• Jabs DA, Prendergast RA, Rorer EM, Hudson AP, Whittum-Hudson JA. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci 2001; 42: 2567–2571
   PubMed Web of Science ®Google Scholar
• Jiang C, Zhao ML, Diaz M. Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis. Immunology 2008; 126: 102–113
   Google Scholar
• Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M, Honjo T, Nussenzweig A, Nussenzweig MC. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 2004; 118: 431–438
   PubMed Web of Science ®Google Scholar
• Takizawa M, Tolarova H, Li Z, Dubois W, Lim S, Callen E, Franco S, Mosaico M, Feigenbaum L, Alt FW, Nussenzweig A, Potter M, Casellas R. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J Exp Med 2008; 205: 1949–1957
   PubMed Web of Science ®Google Scholar
• Kuppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001; 20: 5580–5594
   PubMed Web of Science ®Google Scholar
• Delbos F, De Smet A, Faili A, Aoufouchi S, Weill JC, Reynaud CA. Contribution of DNA polymerase η to immunoglobulin gene hypermutation in the mouse. J Exp Med 2005; 201: 1191–1196
   PubMed Web of Science ®Google Scholar
• Martomo SA, Yang WW, Wersto RP, Ohkumo T, Kondo Y, Yokoi M, Masutani C, Hanaoka F, Gearhart PJ. Different mutation signatures in DNA polymerase η- and MSH6-deficient mice suggest separate roles in antibody diversification. Proc Natl Acad Sci USA 2005; 102: 8656–8661
   PubMed Web of Science ®Google Scholar
• Zeng X, Winter DB, Kasmer C, Kraemer KH, Lehmann AR, Gearhart PJ. DNA polymerase η is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat Immunol 2001; 2: 537–541
   PubMed Web of Science ®Google Scholar
• Xu Z, Zan H, Pal Z, Casali P. DNA replication to aid somatic hypermutation. Adv Exp Med Biol 2007; 596: 111–127
   PubMed Web of Science ®Google Scholar
• Cibere J, Sibley J, Haga M. Systemic lupus erythematosus and the risk of malignancy. Lupus 2001; 10: 394–440
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 1481–1490
   PubMed Web of Science ®Google Scholar
• Hansen A, Lipsky PE, Dorner T. B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol 2007; 3: 561–569
   PubMedGoogle Scholar
• Niller HH, Wolf H, Minarovits J. Regulation and dysregulation of Epstein-Barr virus latency: Implications for the development of autoimmune diseases. Autoimmunity 2008; 41: 298–328
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Clarke A, Ramsey-Goldman R. Malignancy and systemic lupus erythematosus. Curr Rheumatol Rep 2002; 4: 351–358
   PubMedGoogle Scholar
• Zhang JQ, Okumura C, McCarty T, Shin MS, Mukhopadhyay P, Hori M, Torrey TA, Naghashfar Z, Zhou JX, Lee CH, Roopenian DC, Morse HCI, Davidson WF. Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl. J Exp Med 2004; 200: 1467–1478
   Google Scholar
• Unniraman S, Zhou S, Schatz DG. Identification of an AID-independent pathway for chromosomal translocations between the Igh switch region and Myc. Nat Immunol 2004; 5: 1117–1123
   Google Scholar
• Unniraman S, Schatz DG. AID and Igh switch region-Myc chromosomal translocations. DNA Repair 2006; 5: 1259–1264
   Google Scholar